Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Oncotarget ; 8(26): 42548-42559, 2017 Jun 27.
Article in English | MEDLINE | ID: mdl-28476021

ABSTRACT

Obesity is a prominent risk factor for endometrial cancer (EC) and can impede on surgical and hormonal treatments. Markers of EC, estrogen receptor (ER), progesterone receptor (PR), phospho(Ser473)-AKT (pAKT) and 14-3-3 sigma (14-3-3σ) were measured in EC tissues in both the tumor and stroma and grouped by body mass index (BMI). Immunohistochemical scoring of 82 cases of Type 1 and Type II EC tissues revealed a significantly increased tumor expression of ER, PR and 14-3-3σ in women with Type I (BMI < 40) as compared to Type II (BMI < 30) EC. With higher BMI, only PR and 14-3-3σ in the tumor epithelium was significantly higher in Type I than Type II. In particular, Type I EC exhibited significantly increased levels of only PR from patients with BMI > 40 compared to BMI < 40. Type II EC showed increased expression of ER in the stroma only between high and low BMI. Analysis of the TCGA RNA-Seq mRNA expression of ER, PR, PIK3CA, PTEN and SFN (gene for 14-3-3σ) confirmed increased PR expression in EC of obese women. In conclusion, ER, PR and 14-3-3σ are differentially regulated in Type I compared to Type II EC while PR is dysregulated in obese women with Type I EC. These findings have potential implications for efficacy of progestin treatment in obese women.


Subject(s)
14-3-3 Proteins/genetics , Biomarkers, Tumor/genetics , Body Mass Index , Endometrial Neoplasms/etiology , Endometrial Neoplasms/metabolism , Exoribonucleases/genetics , Gene Expression , Receptors, Estrogen/genetics , Receptors, Progesterone/genetics , Stromal Cells/metabolism , 14-3-3 Proteins/metabolism , Biomarkers, Tumor/metabolism , Endometrial Neoplasms/pathology , Exoribonucleases/metabolism , Female , Genomics/methods , Humans , Immunohistochemistry , Obesity/complications , Obesity/metabolism , Receptors, Estrogen/metabolism , Receptors, Progesterone/metabolism , Tissue Array Analysis
2.
Diagn Cytopathol ; 43(5): 432-7, 2015 May.
Article in English | MEDLINE | ID: mdl-25431027

ABSTRACT

Membranous basal cell adenoma (MBCA) is a rare benign salivary gland neoplasm. It is difficult to diagnose MBCA based on fine-needle aspiration (FNA) cytology due to rare reporting of its FNA cytology and overlapping of its FNA cytologic features with some benign and malignant entities. We present a case of MBCA in a 67-year-old female that was originally misinterpreted as adenoid cystic carcinoma (ACC) on FNA cytology. The FNA smears showed numerous uniform small basaloid epithelial cells with round or oval nuclei and inconspicuous nucleoli, and scant cytoplasm. The basaloid cells surround acellular, dense, homogenous material or are surrounded by acellular or paucicellular dense homogeneous material possibly containing bland spindle cells. The basaloid cells are present in variably sized three-dimensional clusters, acini, or sheets with variable cohesion. The dense homogenous material surrounded by basaloid cells may be interconnected. High power magnification reveals the homogeneous material to have a fibrillar texture. The edges of dense homogenous materials were well-demarcated. We describe the diagnostic pitfalls of FNA for MBCA, particularly versus ACC, basal cell adenoma, cellular pleomorphic adenoma, myoepithelioma, basal cell adenocarcinoma, and basaloid squamous cell carcinoma in hope of improving clinical management and patient treatment.


Subject(s)
Adenocarcinoma/diagnosis , Adenoma, Pleomorphic/diagnosis , Adenoma/diagnosis , Carcinoma, Adenoid Cystic/diagnosis , Carcinoma, Squamous Cell/diagnosis , Myoepithelioma/diagnosis , Parotid Neoplasms/diagnosis , Adenocarcinoma/pathology , Adenoma/pathology , Adenoma, Pleomorphic/pathology , Aged , Biopsy, Fine-Needle , Carcinoma, Adenoid Cystic/pathology , Carcinoma, Squamous Cell/pathology , Diagnosis, Differential , Epithelial Cells/pathology , Female , Humans , Myoepithelioma/pathology , Parotid Gland/pathology , Parotid Neoplasms/pathology
SELECTION OF CITATIONS
SEARCH DETAIL
...